TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
Clinical trial NCT05548127 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05548127
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2026-09-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.